Onglyza Heart Failure Concerns Prompt Recommendation from FDA Panel
Even as popular diabetes drugs like Januvia and Actos continue to come under scrutiny, another diabetes drug has recently made headlines. Concerns over Onglyza heart failure have prompted a review by an FDA panel, which could lead to a label change for this drug and others like it. As “mortality”... Read more »